Category Archives: Uncategorized

The retrospective review evaluates the efficacy of a multilayer perceptron (MLP) for IOL power calculation. Source: AAO

• Posted on: Feb 6 2020
• By: Saratoga Opthalmology
• Leave a response

Investigators tested the performance of a second-generation implantable IOP sensor in patients with primary open-angle glaucoma (POAG). Source: AAO

• Posted on: Feb 5 2020
• By: Saratoga Opthalmology
• Leave a response

Researchers assessed the rate of delayed retinal breaks and retinal detachments (RDs) occurring after acute posterior vitreous detachment (PVD). Source: AAO

• Posted on: Feb 4 2020
• By: Saratoga Opthalmology
• Leave a response

This study assessed the sensitivity of ultra-widefield fundus autofluorescence (UWF-FAF) for diagnosing inherited retinal diseases in children. Source: AAO

• Posted on: Feb 3 2020
• By: Saratoga Opthalmology
• Leave a response

This week, a CRISPR trial for inherited blindness gets underway, a first-in-class retinitis pigmentosa treatment gains recognition from the FDA and an unusual retinitis pigmentosa case 50 years in the making. Source: AAO

• Posted on: Jan 31 2020
• By: Saratoga Opthalmology
• Leave a response

This prospective trial evaluated the safety and efficacy of permethrin cream for the treatment of Demodex blepharitis. Source: AAO

• Posted on: Jan 30 2020
• By: Saratoga Opthalmology
• Leave a response

Using data from AREDS and AREDS2, investigators examined the relationship between aspirin use and AMD progression. Source: AAO

• Posted on: Jan 29 2020
• By: Saratoga Opthalmology
• Leave a response

The Academy is sharing important ophthalmology-specific information related to the new 2019-nCoV coronavirus, referred to as “2019-nCoV,” or simply the “Wuhan coronavirus.” Source: AAO

• Posted on: Jan 29 2020
• By: Saratoga Opthalmology
• Leave a response

This study assessed the efficacy of recombinant human nerve growth factor therapy cenegermin (Oxervate) for neurotrophic keratopathy. Source: AAO

• Posted on: Jan 28 2020
• By: Saratoga Opthalmology
• Leave a response

The authors of this prospective trial investigated whether Scheimpflug tomography could be used to predict the prognosis of Fuchs endothelial corneal dystrophy. Source: AAO

• Posted on: Jan 27 2020
• By: Saratoga Opthalmology
• Leave a response